個案總覽

On August 19, 2014, Liberia President Ellen Johnson Sirleaf was faced with an agonizing decision: should she quarantine a densely populated township of Monrovia to halt the spread of the Ebola virus disease? The disease had been ravaging the Republic of Liberia for months but until now, had been isolated in the countryside. Now, the deadly virus was spreading, unchecked, and threatened the 1 million inhabitants of Monrovia, the capital city of the Republic of Liberia. At 5pm she would meet with military and health advisors to hear their recommendations. This case describes the rise and spread of the Ebola virus disease in Liberia and the actions taken by all levels of government, NGOs, volunteers and the community that led to a quarantine within the West Point township. The case is presented in three parts to allow faculty to pose the question, "Should President Sirleaf impose a quarantine?" (A case) before asking students to reconsider the question in light of the community's response to the government and security force actions (B case). An epilogue describes how the West Point community engaged in a peaceful and effective resolution.

An innovative collaboration between the central bank, civil prosecutor's office and the police combine to reduce counterfeit currency.

Avni Patel Thompson, founder and CEO of Poppy, an online marketplace for on-demand childcare, revisits the venture's final months, and discusses the steps she took in the wake of the shutdown. This case explores experiments the company conducted to refine its original business model, as well as how Patel Thompson rekindled her entrepreneurial ambitions. It is part two of an A and B case, the A case being: Poppy: A Modern Village for Childcare Case 818 075, November 2017.

Supplement to case W20203

Supplement to case W20218

Supplement to case W20218

Supplement to case W20218

Supplement to case W20218

Supplement to case W20218

Supplement for product 9B20C018.

Additional Supplement to accompany 9B20M053.

Additional Supplement to accompany 9B20M053.

Additional Supplement to accompany product 9B20M053.

Additional Supplement to accompany 9B20M057.

Additional Supplement to accompany 9B20M058.